Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas

Human Pathology

Volumn 37, Issue 6, 2006, Pages 656-661

  Balasenthil, Seetharaman ^a   Broaddus, Russell R ^a   Kumar, Rakesh ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Corepressors; Endometrial carcinoma; Estrogen receptors; Metastasis associated protein 1

Indexed keywords

METASTASIS ASSOCIATED PROTEIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CELL NUCLEUS; CELL PROLIFERATION; CELL SECRETION; CYTOPLASM; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; POSTMENOPAUSE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ADENOCARCINOMA; CELL NUCLEUS; CYTOPLASM; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; REPRESSOR PROTEINS;

EID: 33745442538     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.01.024     Document Type: Article

References (29)

1. Ellenson L.H., and Wu T.C. Focus on endometrial and cervical cancer. Cancer Cell 5 (2004) 533-538
2. Lax S.F. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 444 (2004) 213-223
3. Irwin J.C., Utian W.H., and Eckert R.L. Sex steroids and growth-factors differentially regulate the growth and differentiation of cultured human endometrial stromal cells. Endocrinology 129 (1991) 2385-2392
4. Jensen E.V., and Jordan V.C. The estrogen receptor: a model for molecular medicine. Clin Cancer Res 9 (2003) 1980-1989
5. Ryan A.J., Susil B., Jobling T.W., et al. Endometrial cancer. Cell Tissue Res 322 (2005) 53-61
6. Imamov O., Shim G.J., Warner M., et al. Estrogen receptor beta in health and disease. Biol Reprod 73 (2005) 866-871
7. Shao W., and Brown M. Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res 6 (2004) 39-52
8. Barnes C.J., Vadlamudi R.K., and Kumar R. Novel estrogen receptor coregulators and signaling molecules in human diseases. Cell Mol Life Sci 61 (2004) 281-291
9. Edwards D.P. The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors. J Mammary Gland Biol Neoplasia 5 (2005) 307-324
10. Glass C.K., Rose D.W., and Rosenfeld M.G. Nuclear receptor coactivators. Curr Opin Cell Biol 9 (1997) 222-232
11. Clarke R., Leonessa F., Welch J.N., et al. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 53 (2001) 25-71
12. Shang Y.F., and Brown M. Molecular determinants for the tissue specificity of SERMs. Science 295 (2002) 2465-2468
13. Gregory C.W., Wilson E.M., Apparao K.B.C., et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab 87 (2002) 2960-2966
14. Shiozawa T., Shih H.C., Miyamoto T., et al. Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J Clin Endocrinol Metab 88 (2003) 871-878
15. Uchikawa J., Shiozawa T., Shih H.C., et al. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression. Cancer 98 (2003) 2207-2213
16. Vadlamudi R.K., Balasenthil S., Broaddus R.R., et al. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors. J Clin Endocrinol Metab 89 (2004) 6130-6138
17. Mazumdar A., Wang R.A., Mishra S.K., et al. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 3 (2001) 30-37
18. Martin M.D., Hilsenbeck S.G., Mohsin S.K., et al. Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Res Treat 95 (2006) 7-12
19. Giannini R., and Cavallini A. Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma. Anticancer Res 25 (2005) 4287-4292
20. Toh Y., Oki E., Oda S., et al. Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 74 (1997) 459-463
21. Toh Y., Kuwano H., Mori M., et al. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 79 (1999) 1723-1726
22. Toh Y., Ohga T., Endo K., et al. Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer 110 (2004) 362-367
23. Iguchi H., Imura G., Toh Y., et al. Expression of MTA1, a metastasis-associated gene with histone deacetylase activity in pancreatic cancer. Int J Oncol 16 (2000) 1211-1214
24. Yi S., Guangqi H., and Guoli H. The association of the expression of MTA1, nm23H1 with the invasion, metastasis of ovarian carcinoma. Chin Med Sci J 18 (2003) 87-92
25. Sasaki H., Moriyama S., Nakashima Y., et al. Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer 35 (2002) 149-154
26. Hofer M.D., Kuefer R., Varambally S., et al. The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 64 (2004) 825-829
27. Moon W.S., Chang K., and Tarnawski A.S. Overexpression of metastatic tumor antigen 1 (MTA1) in hepatocellular carcinoma: relationship to vascular invasion and estrogen receptor-α. Hum Pathol 35 (2004) 424-429
28. Sasaki H., Yukiue H., Kobayashi Y., et al. Expression of the MTA1 mRNA in thymoma patients. Cancer Lett 174 (2001) 159-163
29. Kumar R., Wang R.-A., Mazumdar A., et al. A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature 418 (2002) 654-657